In human prostate cancer xenografts, HE3235 does not transactivate the androgen receptor (AR) and does not antagonize the action of testosterone on AR, but stimulates the androgen response element and PSA expression while decreasing AR expression, inducing apoptosis, and inhibiting androgen synthesis [10, 11]. This evidence concerns the gene AR and Familial prostate cancer.